Clínica Baviera, S.A. (BME:CBAV)
Spain · Delayed Price · Currency is EUR 50.00
+0.50 (1.01%)
At close: Mar 18, 2026
Clínica Baviera Market Cap
Clínica Baviera has a market cap or net worth of €800.93 million as of March 18, 2026. Its market cap has increased by 43.08% in one year.
Market Cap
800.93M
Enterprise Value
821.22M
Revenue
304.91M
Ranking
n/a
PE Ratio
19.38
Stock Price
€50.00
Market Cap Chart
Since April 10, 2007, Clínica Baviera's market cap has increased from 369.53M to 800.93M, an increase of 116.74%. That is a compound annual growth rate of 4.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 800.93M | 0.64% |
| Dec 31, 2025 | 795.80M | 59.55% |
| Dec 31, 2024 | 498.78M | 33.02% |
| Dec 29, 2023 | 374.97M | 31.81% |
| Dec 30, 2022 | 284.48M | -17.68% |
| Dec 30, 2021 | 345.60M | 50.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.66B |
| Laboratorios Farmaceuticos Rovi | 4.04B |
| Almirall | 2.44B |
| Faes Farma | 1.42B |
| Pharma Mar | 1.36B |
| Oryzon Genomics | 218.59M |
| Prim, S.A. | 211.85M |
| Atrys Health | 210.93M |